These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 18653385

  • 1. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH.
    Clin Immunol; 2008 Oct; 129(1):80-9. PubMed ID: 18653385
    [Abstract] [Full Text] [Related]

  • 2. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J.
    J Neurol Sci; 2006 Jul 15; 246(1-2):71-7. PubMed ID: 16581087
    [Abstract] [Full Text] [Related]

  • 3. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 4. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P, Romano MR, Boccardi B, Lombardo F, Moscato G, Mosti S, Baldini C, Nuti S, Meucci G, Rossi B.
    Rev Neurol; 2004 Jul 15; 29(10):893-9. PubMed ID: 10637835
    [Abstract] [Full Text] [Related]

  • 5. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
    Hermans G, Stinissen P, Hauben L, Van den Berg-Loonen E, Raus J, Zhang J.
    Ann Neurol; 1997 Jul 15; 42(1):18-27. PubMed ID: 9225681
    [Abstract] [Full Text] [Related]

  • 6. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb 15; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 7. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.
    Eur J Immunol; 2009 Sep 15; 39(9):2525-36. PubMed ID: 19670379
    [Abstract] [Full Text] [Related]

  • 8. Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
    Jensen J, Krakauer M, Sellebjerg F.
    Cytokine; 2005 Jan 07; 29(1):24-30. PubMed ID: 15579375
    [Abstract] [Full Text] [Related]

  • 9. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F, Polak T, Günther A, Kubuschok B, Janovskaja J, Bitsch A, Poser S, Rieckmann P.
    Ann Neurol; 1998 Jul 07; 44(1):27-34. PubMed ID: 9667590
    [Abstract] [Full Text] [Related]

  • 10. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K, Reder AT.
    Mult Scler; 2007 May 07; 13(4):459-70. PubMed ID: 17463069
    [Abstract] [Full Text] [Related]

  • 11. Measles virus infection of human T cells modulates cytokine generation and IL-2 receptor alpha chain expression.
    Bell AF, Burns JB, Fujinami RS.
    Virology; 1997 Jun 09; 232(2):241-7. PubMed ID: 9191837
    [Abstract] [Full Text] [Related]

  • 12. Cytokine synthesis analyzed at the single-cell level before and after revaccination with tetanus toxoid.
    Fernandez V, Andersson J, Andersson U, Troye-Blomberg M.
    Eur J Immunol; 1994 Aug 09; 24(8):1808-15. PubMed ID: 8056039
    [Abstract] [Full Text] [Related]

  • 13. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D, Thomas AV, Petereit HF, Fink GR, Schroeter M.
    Neuroimmunomodulation; 2009 Aug 09; 16(6):385-91. PubMed ID: 19609087
    [Abstract] [Full Text] [Related]

  • 14. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T.
    Brain; 2004 Sep 09; 127(Pt 9):1917-27. PubMed ID: 15229129
    [Abstract] [Full Text] [Related]

  • 15. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
    Trabattoni D, Saresella M, Pacei M, Marventano I, Mendozzi L, Rovaris M, Caputo D, Borelli M, Clerici M.
    J Immunol; 2009 Oct 15; 183(8):4984-93. PubMed ID: 19794071
    [Abstract] [Full Text] [Related]

  • 16. Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens.
    Venken K, Hellings N, Hensen K, Rummens JL, Stinissen P.
    J Neuroimmunol; 2010 Sep 14; 226(1-2):185-91. PubMed ID: 20554330
    [Abstract] [Full Text] [Related]

  • 17. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
    Sarchielli P, Zaffaroni M, Floridi A, Greco L, Candeliere A, Mattioni A, Tenaglia S, Di Filippo M, Calabresi P.
    Mult Scler; 2007 Apr 14; 13(3):313-31. PubMed ID: 17439900
    [Abstract] [Full Text] [Related]

  • 18. Development of T cell-mediated immunity after autologous stem cell transplantation: prolonged impairment of antigen-stimulated production of gamma-interferon.
    van der Velden AM, Claessen AM, van Velzen-Blad H, Biesma DH, Rijkers GT.
    Bone Marrow Transplant; 2007 Aug 14; 40(3):261-6. PubMed ID: 17563737
    [Abstract] [Full Text] [Related]

  • 19. Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?
    Drulovic J, Savic E, Pekmezovic T, Mesaros S, Stojsavljevic N, Dujmovic-Basuroski I, Kostic J, Vasic V, Mostarica Stojkovic M, Popadic D.
    J Neuroimmunol; 2009 Oct 30; 215(1-2):90-5. PubMed ID: 19695714
    [Abstract] [Full Text] [Related]

  • 20. Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis.
    Wiesemann E, Deb M, Hemmer B, Radeke HH, Windhagen A.
    Clin Immunol; 2008 Sep 30; 128(3):306-13. PubMed ID: 18539537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.